Financhill
Back

Exelixis Vs. Biomarin Pharmaceutical Industry Stock Comparison

Buy
77

EXEL
Exelixis

Last Price:
29.50
Seasonality Move:
14.56%
Sell
41

BMRN
Biomarin Pharmaceutical

Last Price:
70.68
Seasonality Move:
14.67%
Buy
77
Exelixis (EXEL) is a Buy

Is Exelixis a Buy, Sell or Hold?

  • The current Exelixis [EXEL] share price is $28.50. The Score for EXEL is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
  • EXEL is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
41
Biomarin Pharmaceutical (BMRN) is a Sell

Is Biomarin Pharmaceutical a Buy, Sell or Hold?

  • The current Biomarin Pharmaceutical [BMRN] share price is $70.48. The Score for BMRN is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • BMRN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EXEL Stock Price Chart

What is Exelixis's stock price today?

  • The Exelixis share price today is $28.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EXEL is experiencing buying pressure, which is a positive indicator for future bullish movement.

BMRN Stock Price Chart

What is Biomarin Pharmaceutical's stock price today?

  • The Biomarin Pharmaceutical share price today is $70.48
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing buying pressure, which is a positive indicator for future bullish movement.

EXEL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.19 Buy
Relative Strength Index (14 RSI): 69.77 Buy
Chaikin Money Flow: 5265577 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (25.79 - 27.09) Buy
Bollinger Bands (100): (22.08 - 26.38) Buy

BMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.75 Sell
Relative Strength Index (14 RSI): 37.47 Sell
Chaikin Money Flow: 838204 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (66.84 - 76.54) Sell
Bollinger Bands (100): (74.19 - 88.63) Sell

EXEL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 26.31 Buy
20-day SMA: 26.32 Buy
50-day SMA: 26.24 Buy
200-day SMA: 23.29 Buy
8-day EMA: 26.59 Buy
20-day EMA: 26.35 Buy
50-day EMA: 25.79 Buy
200-day EMA: 23.65 Buy

BMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 69.74 Buy
20-day SMA: 69.89 Buy
50-day SMA: 80.46 Sell
200-day SMA: 84.59 Sell
8-day EMA: 70.03 Buy
20-day EMA: 71.77 Sell
50-day EMA: 76.85 Sell
200-day EMA: 83.33 Sell

Exelixis Earnings Growth & EXEL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.93 per share, and a decrease next year of $0.04 per share.

Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.18 per share, and an increase next year of $0.97 per share.

Exelixis Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Biomarin Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):